Tag: biosimilars
Biosimilar Cost Savings: How They Compare to Original Biologic Prices
Biosimilars offer significant cost savings compared to original biologic drugs, with real-world examples showing up to 85% lower prices. Despite proven safety and effectiveness, adoption remains low due to rebate systems and market barriers. Learn how much patients and systems are saving-and why more savings are still possible.
Global Biosimilar Markets: Europe vs United States - How Regulations and Adoption Differ
Europe led the world in biosimilar adoption since 2006, while the US lagged due to legal and regulatory barriers. Now, with new FDA rules and patent expirations, the US is catching up fast - changing how patients access affordable biologic drugs.
About
Healthcare Information